US 10258613
Compositions for treating retinal degeneration and methods of production and use thereof
granted A61KA61K31/085A61K31/09
Quick answer
US patent 10258613 (Compositions for treating retinal degeneration and methods of production and use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/085, A61K31/09, A61K31/16, A61K31/17